Efficacy of Tramadol With Ropivacaine for Modified Pectoral Nerve Block in Breast Cancer Surgery
Comparison of Post Operative Analgesia Between 0.25% Ropivacaine and 0.25% Ropivacaine Combined With Tramadol in Ultrasound Guided Modified Pectoral Nerve Block for Patient Undergoing Modified Radical Mastectomy.
1 other identifier
interventional
62
1 country
1
Brief Summary
In this study the investigators will compare the post operative opoid consumption for patient undergoing modified radical mastectomy. The patients will be divided into two groups one group will receive modified pectoral nerve block with local anesthetic ropivacaine combined with tramadol and other group will receive pectoral nerve block with ropivacaine only
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable postoperative-pain
Started Jan 2026
Typical duration for not_applicable postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 22, 2026
CompletedFirst Submitted
Initial submission to the registry
August 15, 2026
CompletedFirst Posted
Study publicly available on registry
August 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2027
August 24, 2026
August 1, 2026
1.5 years
August 15, 2026
August 20, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Postoperative Pain with visual analogue scale
Post operatively pain will be accessed by visual analogue scale . Visual analogue scale (VAS) scale has score from 0 to 10 where 0 score indicate no or minimal pain and score of 10 indicate worst possible pain.
24 hours postoperatively
Study Arms (2)
Ropivacaine with tramadol
OTHERRopivacaine Alone
OTHERInterventions
One group will receive ropivacaine with tramadol in modified pectoral nerve block
Eligibility Criteria
You may qualify if:
- Female Patients aged 20-70 years
- Patients scheduled for elective unilateral modified radical mastectomy
- Patients with ASAI andII physical status.
You may not qualify if:
- Patients on anticoagulant therapy.
- Patients with a BMI≥35 kg/m3.
- Patients with a history of allergy to local anesthetics.
- Patients with significant neurological or psychiatric disorders.
- Pregnant patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dr Faisal Masood teaching Hospital Sargodha
Sargodha, Punjab Province, 40100, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 15, 2026
First Posted
August 20, 2026
Study Start
January 22, 2026
Primary Completion (Estimated)
August 1, 2027
Study Completion (Estimated)
August 1, 2027
Last Updated
August 24, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share